Home Technology OnePlus 8 sale started today at 2pm via Amazon, Price and Specs

OnePlus 8 sale started today at 2pm via Amazon, Price and Specs

OnePlus 8 goes for sale first time in India on Monday. This special sale was held on Amazon India at 2PM IST. Launched last month alongside the OnePlus 8 Pro.

OnPlus 8 comes with 90HZ Fluid display and is powered by Snapdragon 865 processor. It comes with a curved design and sports 48-megapixel triple cameras and supports 30W fast charging

OnePlus Variants Price
1) 6GB + 128GB model priced at Rs 41,999
2) 8GB + 128GB model costs Rs 44,999
3) 8GB + 256GB model costs Rs 49,999

OnePlus Colour Variants
Glacial Green, Interstellar Glow, Onyx Black

Phone Specs

ProcessorQualcomm Snapdragon 865 | 6 GB
Display6.55 inches full HD+ Fluid AMOLED
Rear Camera48MP + 16MP + 2MP
Front Camera16MP
Battery4300 mah
OSAndroid 10 OS with OxygenOS skin
Phone Specs

Offers on OnePlus 8
State Bank of India customers can get flat Rs2,000 off with SBI cards and No cost EMI transactions across all variants. Customers who pre-booked the OnePlus 8 can get additional Rs 1,000 vash back on Amazon Pay.

Latest

SBI cautions against hackers; dos and dont’s to prevent fraud

State Bank of India (SBI) has cautioned its customers to guard themselves from cyber thugs. Through a video tweet, the bank has...

Delhi receives heavy rainfall overnight, aread flooded

Delhi & neighbouring areas received heavy rainfall in the night. THe weather department has predicted moderate rain and thunderstorms...

PM Modi: National Recruitment Agency will be boon for youngsters

PM Modi: National Recruitment Agency will be boon for youngsters PM Modi said on Wednesday, The National Recruitment Agency...

Nearly 11 Lakh Indians return under Vande Bharat Mission

More than 10,98,000 Indians stranded abroad in foreign countries due to the pandemic have returned to India under the Vande Bharat Mission...

Drug Makers asked to indicate the prices of Covid-19 vaccines

The development and trails of covid-19 vaccine in India are progressing good and the drug manufacturers have been asked to indicate potential...